Fulcrum Therapeutics Inc (FULC)
7.055
-0.10
(-1.33%)
USD |
NASDAQ |
Apr 18, 16:00
7.055
0.00 (0.00%)
After-Hours: 17:58
Fulcrum Therapeutics Cash from Operations (TTM): -90.96M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -90.96M |
September 30, 2023 | -87.50M |
June 30, 2023 | -92.48M |
March 31, 2023 | -99.06M |
December 31, 2022 | -97.05M |
September 30, 2022 | -99.21M |
June 30, 2022 | -93.90M |
March 31, 2022 | -84.36M |
December 31, 2021 | -78.48M |
September 30, 2021 | -76.45M |
June 30, 2021 | -58.38M |
Date | Value |
---|---|
March 31, 2021 | -54.68M |
December 31, 2020 | -53.66M |
September 30, 2020 | -38.32M |
June 30, 2020 | -46.84M |
March 31, 2020 | -44.79M |
December 31, 2019 | -39.48M |
September 30, 2019 | -41.39M |
June 30, 2019 | -32.49M |
March 31, 2019 | -25.83M |
December 31, 2018 | -22.56M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-99.21M
Minimum
Sep 2022
-32.49M
Maximum
Jun 2019
-68.92M
Average
-76.45M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
Pfizer Inc | 8.70B |
NovaBay Pharmaceuticals Inc | -4.131M |
Palatin Technologies Inc | -26.54M |
iBio Inc | -18.89M |
Theriva Biologics Inc | -19.00M |